CGTX

NASDAQStock

Cognition Therapeutics, Inc.

$1.05-0.03 (-2.31%)

52-Week Range

$0.24

$3.18

Key Stats

Market Cap

77.6M

P/E Ratio

—

Dividend Yield

—

Beta

1.25

Volume

380.1K

Avg Volume

649.8K

Performance

-3.57%

-32.50%

-32.92%

YTD

-26.53%

+141.66%

-42.25%

-91.54%

Price Chart

ETF Exposure

CGTX is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IBRN	iShares Neuroscience and Healthcare ETF	0.13%	5,385	$6K	$4.7M	0.47%
VXF	Vanguard Extended Market ETF	0.00%	874,810	$954K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	101	$149	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	3,612	$5K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	17	$25	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	2,056,395	$2.2M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	10,816	$16K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	932	$1K	$1.29B	0.17%

About CGTX ETF Exposure

Cognition Therapeutics, Inc. (CGTX) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 77.6M, CGTX is a widely held institutional stock. The stock currently trades at $1.05. Investors can gain exposure to CGTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CGTX, sorted by portfolio weight.